Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Can Cannabis Enhance Outcomes in Group Therapy for Depression? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

The idea of cannabis group therapy for depression  is being explored as clinicians and patients consider whether cannabinoids could improve participation in group-based treatments. Group therapy relies on openness, trust, and social interaction, all of which can be difficult for people living with depression. Some suggest that cannabis, particularly CBD, may reduce anxiety and encourage greater engagement in these settings. 

CBD may ease tension and make patients feel calmer when sharing in groups, while low doses of THC are sometimes linked to improved sociability. However, higher doses of THC may have the opposite effect, reducing focus or increasing self-consciousness. 

Is Medical Cannabis Legal in UK?

Cannabis And Group Engagement 

Research into cannabis group therapy for depression considers whether cannabinoids can support collaboration and openness in peer-based environments. 

Social Interaction 

Cannabis may improve social interaction by lowering anxiety and helping individuals feel more relaxed around others, supporting more authentic communication. 

Therapy Participation 

By reducing stress and emotional barriers, cannabis may increase therapy participation, allowing patients to contribute more fully to discussions and activities. 

Peer Support 

Some patients describe cannabis as helping them access the benefits of peer support, feeling more connected to others with similar experiences. This can enhance the overall therapeutic value of group sessions. 

In summary, while cannabis group therapy for depression may hold potential for improving engagement, evidence remains limited. More structured trials are needed to confirm whether cannabis reliably enhances group therapy outcomes. 

For patients considering whether cannabis could complement group-based treatments, providers like LeafEase can offer supportive consultations tailored to safe and personal care. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Depression.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories